The pharmaceutical industry is constantly and rapidly changing because of changes in technology, research and development (R&D), regulations, competition, and demand for pharmaceuticals. Increased competition will drive industry change as the use of less expensive generic and over-the-counter drugs ...
In stark contrast, Chinese generic manufacturers have engaged in intense cost competition, driving prices down to levels that are nearly unthinkable. For example, aspirin was priced as low as 0.034 yuan per tablet, bringing the cost of a one-month supply to just 1 yuan, and a full year’s...
Technological advancements and innovations in drug developmentare shaping the market dynamics. The introduction of new drug formulations and delivery systems, such as long-acting injectables and oral disintegrating tablets, is enhancing the effectiveness and patient ...
In stark contrast, Chinese generic manufacturers have engaged in intense cost competition, driving prices down to levels that are nearly unthinkable. For example, aspirin was priced as low as 0.034 yuan per tablet, bringing the cost of a one-month supply to just 1 yuan, and a full year’s ...
This trend is expected to continue driving growth in the generic sterile injectables market for oncology drugs. Development of Complex Oncology Drugs: The oncology drug market is witnessing a shift toward the development of more complex and targeted therapies. These drugs are often monoclonal ...
The next big generics development is the introduction of regulatory pathways for biogenerics. These are generic versions of biotechnology-based drugs (biopharmaceuticals or biologics) such as insulin and human growth hormone, that is, large-protein molecules derived from living cells. Biogenerics involve...
Curia is a global CDMO with over 30 years of experience successfully guiding clients through the complexities of drug discovery, development, and manufacturing. We offer services across Small Molecules, Generic APIs, and Biologics backed by deep scientific expertise and a robust global network of reso...
This trend is expected to continue driving growth in the generic sterile injectables market for oncology drugs. Development of Complex Oncology Drugs: The oncology drug market is witnessing a shift toward the development of more complex and targeted therapies. These drugs are often monoclon...
Discover how Veeda Lifesciences leverages technology and expertise to streamline drug development. Learn about our tech-driven solutions and oncology breakthroughs.
This trend is expected to continue driving growth in the generic sterile injectables market for oncology drugs. Development of Complex Oncology Drugs: The oncology drug market is witnessing a shift toward the development of more complex and targeted therapies. These drugs are often monoclo...